Partnerships, Dedication Within Pharmaceutical Industry Have "Contributed Greatly" to AIDS Progress

PhRMA President and CEO John Castellani reflects on the role of partnerships and dedication within the pharmaceutical industry in the global AIDS response in the Huffington Post's "Impact" blog, writing, "The determination to research and develop medicines to fight HIV/AIDS has contributed greatly to the steady decrease in AIDS-related deaths worldwide, from the peak of 2.1 million in 2004 to an estimated 1.8 million in 2009, according to the 2010 UNAIDS Report on the Global AIDS Epidemic." He highlights three global AIDS challenges -- "ensuring new medicines and training are available on an emergency basis, forging innovative partnerships that build a sustainable infrastructure that enables safe delivery of treatment and licensing manufacturing to foreign governments to allow patients to access lower cost or no cost treatments" -- discusses recent progress, and concludes, "Our determination and pursuit of eradication lives in the 88 medicines and vaccines currently in development and the research that is currently under way at dozens of facilities across the world" (7/24).

Back to other news for July 2012